ESRA19-0079\u2005Audit of usage of cell salvage within maternity unit

Abstract

Background and aims Obstetric haemorrahge remains a major cause of maternal mortality in the United Kingdom. UKOSS figures showed that with 3000 deliveries per year, we would expect to see 1–2 peripartum hysterectomies due to haemorrhage. Intraoperative cell salvage is efficacious technique for blood replacement in which RBCs lost during surgery are recovered, washed and reinfused to the patient. A retrospective audit was undertaken from May 2011 to April 2014 in maternity unit of our hospital. Recommendations made at end of audit were discussed at maternity care forum and agreed that cell saver would be used for all out of hours caesarean sections and high risk cases in-hours. Methods The objective of the audit was to find out whether cell saver was used for all out of hours caesarean sections and for high risk cases in-hours. A retrospective audit from 11/04/2017 to 29/06/2017 was undertaken. The data collected when cell saver is used within maternity unit was reviewed for the above period to identify how and when the cell saver is used. Results A total of 125 caesarean sections were done during this time. Cell saver was used in 50 cases with 28 in hours and 22 out of hours. Cell saver was processed in only 3 cases and blood was reinfused only in 2 cases. Conclusions We are compliant in using cell saver in high risk patients. we are also compliant in using cell saver for emergency caesarean section during out of hours. We are using cell saver during in-hours routinely for emergency caesarean sections.